...FDA approved Symtuza darunavir/cobicistat/emtricitabine/tenofovir alafenamide from Johnson & Johnson (NYSE:JNJ) to treat HIV-1 infection in adults who...
...Symtuza darunavir/cobicistat/emtricitabine/tenofovir alafenamide Business: Infectious Jaime De Leon Prezista (Brand), TMC114 (Compound #), darunavir (Generic), Prezista (Informal) Symtuza (Brand), Darunavir/cobicistat/emtricitabine/tenofovir alafenamide...
...Business: Infectious Jaime De Leon Prezista (Brand), TMC114 (Compound #), darunavir (Generic), Prezista (Informal) Symtuza (Brand), Darunavir/cobicistat/emtricitabine/tenofovir alafenamide (Generic), Symtuza...

...& Development LLC unit submitted an NDA to FDA for a once-daily fixed-dose combination of darunavir/cobicistat/emtricitabine/tenofovir alafenamide...
...12 and older. Also in September, the European Commission approved the combination under the name Symtuza...
...Foster City, Calif. Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. Product: Symtuza darunavir/cobicistat/emtricitabine/tenofovir alafenamide Business: Infectious Meghan Sullivan Symtuza Gilead Johnson...

...Janssen-Cilag International N.V. unit submitted an MAA to EMA for a once-daily fixed-dose combination of darunavir/cobicistat/emtricitabine/tenofovir alafenamide...